alan venook, md, on the keynote-177 study investigating msi high/mismatch repair deficient mcrc

Published 4 years ago • 67 plays • Length 3:22

Download video MP4
Download video MP3

Similar videos

3:08

alan venook, md, discusses uniqueness of msi-high/mismatch repair deficient crc patients
2:16

alan venook, md, describes the potential practice changing results of the keynote-177 study
2:12

alan venook, md, considers how i-o is evolving towards the first line treatment of colorectal cancer
1:39

alan venook, md, discusses next generation sequencing and mcrc treatment
2:16

alan venook, md, on potential new standard in care post approval of atezolizumab bevacizumab
$william trattler, md: the oculus pentacam® - case presentations, screening for refractive surgery$ 8:10

william trattler, md: the oculus pentacam® - case presentations, screening for refractive surgery
15:26

thomas kohnen, md – iol master vs. pentacam® axl
1:08:22

diagnosing alzheimer’s disease in the biomarker era: promises and pitfalls | professor ron petersen
1:47

alan venook, md discusses development of immunotherapies for non msi-high crc patients
1:44

alan venook, md, considers how immunotherapy is being integrated into crc treatment algorithms
1:38

alan venook, md explains the outcome of phase 3 calgb/swog 80405 study
1:18

alan venook, md, on the latest in identifying valid biomarkers in the treatment of hcc
5:35

howard hochster, md, discusses the outcomes of the keynote-177 study in metastatic crc
1:30

alan venook, md, discusses vemurafenib and the nccn guidelines for mcrc patients
1:05

alan p. venook, md, on integrating immunotherapy into treatment regimens for gastric cancer patients
2:59

alan venook, md, provides opinions of the opra data in rectal cancer patients presented at asco20
1:41

alan p. venook, md, explains how the 80405 study and its impact on treatment guidelines
1:01

alan venook, md, balancing economics with the efficacy outcomes seen in 80405
1:16

howard hochster md, provides thoughts on potential practice changing results of the keynote177 study
2:03

alan venook, md, explains the biological difference between left-sided and right-sided crc tumors
1:54

alan venook, md, explains how tumor sidedness affects therapeutic choice
0:48

dr. venook discusses the future of colorectal cancer treatment

Clip.africa.com - Privacy-policy